New TyG-ABSI Index Outperforms Traditional Markers for Heart Disease Risk
Large NHANES study shows TyG-ABSI index better predicts cardiovascular disease and death in metabolic syndrome patients than standard measures.
4489 articles
Large NHANES study shows TyG-ABSI index better predicts cardiovascular disease and death in metabolic syndrome patients than standard measures.
New review examines cardiovascular safety of popular sugar substitutes erythritol and xylitol amid recent concerns about clotting risk.
Meta-analysis of 63 studies reveals sleep problems are widespread in Parkinson's disease, with late-onset cases showing worse outcomes.
New review exposes stark disparities in diabetes care across Asia-Pacific, from insulin access to advanced technologies like CGM and pumps.
New cryo-EM structures reveal how LYCHOS protein senses cholesterol levels to regulate mTORC1 signaling, offering drug targets for aging.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
New research identifies YTHDF1 as a key factor that determines how mTORC1 signaling contributes to various aging processes.
New research shows preeclampsia disrupts cardiovascular development in both mothers and babies, creating lasting disease risk.
New spatial multiomics study maps cellular interactions in systemic sclerosis, revealing fibroblast-macrophage dynamics.
Blocking METTL3 enzyme boosts cellular cleanup in kidney cells and reduces glomerular damage in chronic kidney disease models.
Novel mineralized collagen scaffold promotes healing of tendon-bone connections across multiple animal models with 82% recovery rate.
New research explores how a specific probiotic strain could combat depression by modulating the gut-brain axis through neurotransmitter production.